NPAC-AIIPC Announces New President & CEO
NPAC-AIIPC President & CEO Dr. Jennifer Beaveridge, MScN, DNP, NP(F)VANCOUVER, BC / ACCESSWIRE / January 16, 2024 / The Nurse...
Day: January 16, 2024
Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments
Financing advances development of Prota's peanut allergy remission therapy in preparation for a Phase 3 clinical trialMELBOURNE, AUSTRALIA / ACCESSWIRE...
CordovaCann (CSE:CDVA / OTCQG:LVRLF) Provides Update On Star Buds Cannabis Co. Retail Operations
Star Buds Cannabis Co. Stores Have Strong Close to 2023TORONTO, ON / ACCESSWIRE / January 16, 2024 / CordovaCann Corp....
CLS Holdings USA Inc. (“CLSH”) Announces Repayment of $3,875,094 in Principal Debenture Obligations
LAS VEGAS, NV / ACCESSWIRE / January 16, 2024 / This Debt Retirement eliminates a total of $4,340,101 in Principal...
Vizzia Technologies Achieves Remarkable 112% Healthcare RTLS Growth in 2023
Continued Industry Leadership of Real-Time Data Analytics for Major U.S. HospitalsATLANTA, GA / ACCESSWIRE / January 16, 2024 / Vizzia...
Renalogic Partners With Springbuk in Innovative, New Health Intelligence Marketplace for Employers and Benefits Advisors
CHICAGO, IL / ACCESSWIRE / January 16, 2024 / Renalogic, a market leader helping self-funded group plans and their health...
Update Provided on GBB Drink Lab, Inc. Litigation and Safety Shot
TORONTO, ON / ACCESSWIRE / January 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), is a...
Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC)
Alice will lead the organization's IMC division made up of experts in medical strategy, medical communications, publications planning and delivery,...
ASCEND’s Telepresence Technology, Catalyst LIVE, Transforms Diagnostic Imaging
CHICAGO, IL / ACCESSWIRE / January 16, 2024 / ASCEND Cardiovascular's newest technology, Catalyst LIVE, currently implemented at two pioneering...
Pressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January
Uncle Bud’s, PBIO’s New Consumer Products Business Unit, Kicks Off 2024 with a $252,000 Shipment of Sunburn Soother to One of...
Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement Update
Reports initial reimbursements of CompuFlo® by commercial payors and MedicareROSELAND, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc....
NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New Client
Project reflects Scorpius’ versatility through its multi-functional biologics facility and expertise in microbial fermentationDURHAM, N.C., Jan. 16, 2024 (GLOBE NEWSWIRE)...
Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference
BOSTON, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing...
Nanox Mourns Death of Its Founder, Ran Poliakine
PETACH TIKVA, Israel, Jan. 16, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative...
Biomerica Reports Second Quarter 2024 Financial Results
Revenues excluding Covid test sales increased 10.3% for the second fiscal quarter of 2024 vs the second fiscal quarter of...
Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
– Patient dosing expected to begin mid-to-late Q1 2024 – CHARLESTOWN, Mass., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences...
Instil Bio Announces Strategic Update
DALLAS, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil” or the “Company”) (NASDAQ: TIL), a clinical-stage biopharmaceutical company...
Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to develop optimal clinical model for investigational COMP360 psilocybin treatment, if FDA-approved
LONDON, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient...
Genevant Sciences to Collaborate with Tome Biosciences to Develop Gene Editing Therapeutic for Rare Liver Disorder
VANCOUVER, British Columbia, and BASEL, Switzerland, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company...
PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference
PRINCETON, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or “the Company”), a clinical-stage...